Yongsheng Liu

IOPtima Ltd. develops minimally-invasive surgical ophthalmic devices. The firm offers IOPtimate, a laser based surgical system to treat patients with primary open-angle glaucoma and pseudo-exfoliative glaucoma. Its IOPtimate utilizes a CO2 laser technology to reduce internal eye pressure by restoring the natural fluid percolation without penetrating into the eye. The company was founded in 2005 and is headquartered in Kiryat Atidim, Israel.

IOPtima Ltd. develops minimally-invasive surgical ophthalmic devices. The firm offers IOPtimate, a laser based surgical system to treat patients with primary open-angle glaucoma and pseudo-exfoliative glaucoma. Its IOPtimate utilizes a CO2 laser technology to reduce internal eye pressure by restoring the natural fluid percolation without penetrating into the eye. The company was founded in 2005 and is headquartered in Kiryat Atidim, Israel.

IOPtima Ltd. develops minimally-invasive surgical ophthalmic devices. The firm offers IOPtimate, a laser based surgical system to treat patients with primary open-angle glaucoma and pseudo-exfoliative glaucoma. Its IOPtimate utilizes a CO2 laser technology to reduce internal eye pressure by restoring the natural fluid percolation without penetrating into the eye. The company was founded in 2005 and is headquartered in Kiryat Atidim, Israel.

IOPtima Ltd. develops minimally-invasive surgical ophthalmic devices. The firm offers IOPtimate, a laser based surgical system to treat patients with primary open-angle glaucoma and pseudo-exfoliative glaucoma. Its IOPtimate utilizes a CO2 laser technology to reduce internal eye pressure by restoring the natural fluid percolation without penetrating into the eye. The company was founded in 2005 and is headquartered in Kiryat Atidim, Israel.

IOPtima Ltd. develops minimally-invasive surgical ophthalmic devices. The firm offers IOPtimate, a laser based surgical system to treat patients with primary open-angle glaucoma and pseudo-exfoliative glaucoma. Its IOPtimate utilizes a CO2 laser technology to reduce internal eye pressure by restoring the natural fluid percolation without penetrating into the eye. The company was founded in 2005 and is headquartered in Kiryat Atidim, Israel.